Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Recruiting · NCT05830500 · Registry updated 2023-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | Carcinoma, Medullary, Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, medullary thyroid gland carcinoma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 4 | 2023-07-25 | NCT05830500 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.